Sponsor or institution
Clinical trials and research at Regor Pharmaceuticals Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Regor Pharmaceuticals Inc. that are recruiting, in United States. By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
RGT-490 for adults with PIK3CA-mutated advanced solid tumors
This trial will test RGT-490, an oral medicine, in adults whose advanced solid tumors carry a PIK3CA mutation and have progressed after prior therapy.
-
Evaluating RGT-419B for advanced breast cancer treatment
This study is testing a new drug called RGT-419B to see if it can help people with advanced breast cancer who haven't responded to previous treatments.
Quick answers
How many clinical trials run by Regor Pharmaceuticals Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.